These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 9313057)

  • 1. [Effectiveness of ciprofloxacin in the treatment of hospital infections of the lower respiratory tract].
    Chuchalin AG; Novikov IuK; Avdeev SN; Belevskiĭ AS
    Antibiot Khimioter; 1997; 42(6):34-8. PubMed ID: 9313057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quinolones in everyday clinical practice: respiratory tract infections and nosocomial pneumonia.
    Marklein G
    Chemotherapy; 1996 Mar; 42 Suppl 1():33-42. PubMed ID: 8861533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of intravenous ciprofloxacin in patients with nosocomial lower respiratory tract infections. Impact of plasma concentrations, organism, minimum inhibitory concentration, and clinical condition on bacterial eradication.
    Peloquin CA; Cumbo TJ; Nix DE; Sands MF; Schentag JJ
    Arch Intern Med; 1989 Oct; 149(10):2269-73. PubMed ID: 2508586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy, safety and pharmacokinetics of intravenous ciprofloxacin in patients with lower respiratory tract infections.
    Ohmichi M; Hiraga Y
    J Int Med Res; 1999; 27(6):297-304. PubMed ID: 10726239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of severe nosocomial pneumonia: a prospective randomised comparison of intravenous ciprofloxacin with imipenem/cilastatin.
    Torres A; Bauer TT; León-Gil C; Castillo F; Alvarez-Lerma F; Martínez-Pellús A; Leal-Noval SR; Nadal P; Palomar M; Blanquer J; Ros F
    Thorax; 2000 Dec; 55(12):1033-9. PubMed ID: 11083889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind study of once-daily temafloxacin in the treatment of bacterial lower respiratory tract infections.
    Kosmidis J
    J Antimicrob Chemother; 1991 Dec; 28 Suppl C():73-9. PubMed ID: 1664832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of lower respiratory tract infections in the elderly].
    Komarova VP; Belousov IuB; Sokolov AV; Tishchenkova IF; Efremenkova OV
    Antibiot Khimioter; 1997; 42(12):19-24. PubMed ID: 9480649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical studies on ciprofloxacin in chronic respiratory tract infection].
    Yoshida M; Watanabe K; Tamaru N; Ishibashi T; Takamoto M; Yamada H; Katoh O; Yamaguchi T; Ando M; Matsumoto M
    Jpn J Antibiot; 1991 May; 44(5):506-14. PubMed ID: 1880930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety in the oral treatment of purulent chest disease and pneumonia with cefixime, ofloxacin, and ciprofloxacin.
    Brückner O; Trautmann M
    J Chemother; 1989 Jul; 1(4 Suppl):782-3. PubMed ID: 16312637
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical and microbiological evaluation of pefloxacin in lower respiratory tract infections.
    Tatsis G; Tsoukalas G; Hatzinikolaou V; Boulbasakos G; Jordanoglou J
    J Int Med Res; 1996; 24(6):478-81. PubMed ID: 8959532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of fluoroquinolones in lower respiratory tract infections.
    Vellend H
    Clin Invest Med; 1989 Feb; 12(1):39-43. PubMed ID: 2920482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized, double-blind study of prulifloxacin versus ciprofloxacin in patients with acute exacerbations of chronic bronchitis.
    Grassi C; Salvatori E; Rosignoli MT; Dionisio P;
    Respiration; 2002; 69(3):217-22. PubMed ID: 12097764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and tolerability of twice-daily ciprofloxacin 750 mg in the treatment of patients with acute exacerbations of chronic bronchitis and pneumonia.
    Pryka R; Kowalsky S; Haverstock D
    Clin Ther; 1998; 20(1):141-55. PubMed ID: 9522111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of oral ciprofloxacin in the treatment of serious respiratory infections.
    Fass RJ
    Am J Med; 1987 Apr; 82(4A):202-7. PubMed ID: 3555037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical evaluation of ciprofloxacin in pulmonary infections in the patients with chronic respiratory diseases].
    Kikuchi N; Kawashima T; Yamagishi F; Suzuki K; Yasuda J; Niijima Y; Mizutani F; Tabeta H
    Jpn J Antibiot; 1991 Aug; 44(8):839-45. PubMed ID: 1920809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of ciprofloxacin in children with mucoviscidosis].
    Kapranov NI; Kashirskaia NIu; Semykin SIu; Belousov IuB
    Antibiot Khimioter; 1997; 42(6):39-41. PubMed ID: 9313058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ciprofloxacin in the treatment of bronchopulmonary infections].
    Girbino G; Giacobbe G; Quattrone G; Fiorello G
    Riv Eur Sci Med Farmacol; 1990; 12(4-5):259-63. PubMed ID: 2103966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and economic evaluation of subsequent infection following intravenous ciprofloxacin or imipenem therapy in hospitalized patients with severe pneumonia.
    Caldwell JW; Singh S; Johnson RH
    J Antimicrob Chemother; 1999 Mar; 43 Suppl A():129-34. PubMed ID: 10225583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of patients with pneumonia, chronic obstructive bronchitis and mucoviscidosis with cefpirome].
    Chuchalin AG; Sokolov AS; Apul'tsina ID; Avdeev SN; Gugutsidze EN; Kuchkina NV
    Antibiot Khimioter; 1996; 41(12):14-8. PubMed ID: 9124979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ciprofloxacin therapy of respiratory tract infection with Pseudomonas aeruginosa.
    Haverkorn MJ
    Eur J Clin Microbiol Infect Dis; 1988 Oct; 7(5):661-4. PubMed ID: 3143577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.